For AD, three autoantibodies against brain-specific antigens, glia-derived nexin (SERPINE2), fibromodulin (FMOD) and quinone oxidoreductase (NQO1), were absent in CSF of all patients in the control group and were present in eight, six and five patients with AD, respectively (Table 2). Here, NQO1 is linked to Alzheimer disease.